Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA expression of TS, MTHFR, and DPD as predictors of neoadjuvant 5-FU chemotherapy response in advanced colorectal cancer
TCTR20240618004Completed
- Sponsor
- Self-Funded Health
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of fluorouracil in colorectal cancer (CRC), sponsored by Self-Funded Health. Primary endpoint: Predictive value of TS, MTHFR, and DPD mRNA expression. Started Feb 2024; status: completed.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on TCTR20240618004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240618004.